BIIB: Biogen Inc. Stock

by  •  • Comments Off on BIIB: Biogen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 23,207.26
Enterprise Value ($M) 27,801.96
Book Value ($M) 16,358.90
Book Value / Share 112.26
Price / Book 1.42
NCAV ($M) -5,123.80
NCAV / Share -35.16
Price / NCAV -4.53

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 0.80
Current Ratio 1.26

Balance Sheet (mrq) ($M)
Current Assets 6,830.50
Assets 28,313.20
Liabilities 11,954.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Vanguard Group Inc 11.44 0.00
10-16 13G State Street Corp 5.00
08-07 13G/A BlackRock, Inc. 10.10 2.81
02-12 13G/A Primecap Management Co/ca/ 11.22 3.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-12-06 136,992 730,974 18.74
2024-12-05 153,425 816,690 18.79
2024-12-04 165,792 693,271 23.91
2024-12-03 212,497 964,367 22.03

(click for more detail)

Similar Companies
BCRX – BioCryst Pharmaceuticals, Inc. BDTX – Black Diamond Therapeutics, Inc.
BEAM – Beam Therapeutics Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc.


Financial data and stock pages provided by
Fintel.io